open access
Oncogenic osteomalacia — detection of the tumour site upon physical examination
Affiliations- Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
- Outpatient Endocrinology Unit, Copernicus, Gdansk, Poland
- Department of General, Endocrine, and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland
- Department of Radiology, Medical University of Gdansk, Gdansk, Poland
- Department of Pathology, Medical University of Gdansk, Gdansk, Poland
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
FGF23; oncogenic osteomalacia; phosphaturic mesenchymal tumour; hypophosphataemia
Supp./Additional Files (1)
About this articleTitle
Oncogenic osteomalacia — detection of the tumour site upon physical examination
Journal
Issue
Article type
Clinical vignette
Pages
792-793
Published online
2022-06-29
Page views
4083
Article views/downloads
412
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(4):792-793.
Keywords
FGF23
oncogenic osteomalacia
phosphaturic mesenchymal tumour
hypophosphataemia
Authors
Ewa Zalewska
Monika Płoszaj-Neć
Sonia Kaniuka-Jakubowska
Anna Orzechowska-Pawiłojć
Maciej Śledziński
Maciej Piskunowicz
Wojciech Biernat
Krzysztof Sworczak
References (4)- Kaniuka-Jakubowska S, Biernat W, Lewczuk A, et al. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures. Endokrynol Pol. 2012; 63(3): 234–238.
- Pal R, Agrawal K, Gupta S, et al. Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone. Endokrynol Pol. 2020; 71(1): 102–103.
- Dutta D, Pandey RK, Gogoi R, et al. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes. Endokrynol Pol. 2018; 69(2): 205–210.
- Yu WJ, He JW, Fu WZ, et al. Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab. 2017; 35(3): 298–307.
